Anlotinib Retrospective Study for Esophageal Cancer

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05013697` - TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.	Phase 2
Completed	`NCT02128243` - Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer	Phase 2
Completed	`NCT02253602` - Innovative MRI Techniques to Improve Treatment Stratification of Patients With Esophageal Cancer	N/A
Completed	`NCT01900691` - Removal of the Evolution® Esophageal Stent - Fully Covered	N/A
Completed	`NCT01719926` - Phase I Platinum Based Chemotherapy Plus Indomethacin	Phase 1
Terminated	`NCT01572987` - Endoscopic Resection or Ablation for Patients With Dysplasia or Cancer Requiring Treatment of Barrett's Esophagus	N/A
Terminated	`NCT00760604` - A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer	Phase 3
Completed	`NCT00160030` - Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer	Phase 2
Suspended	`NCT00048529` - Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus	Phase 2
Recruiting	`NCT05007106` - MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)	Phase 2
Completed	`NCT02284802` - Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy	N/A
Terminated	`NCT03223662` - Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy	Phase 2
Completed	`NCT05680077` - KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method)
Completed	`NCT03549494` - Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction	Phase 2
Completed	`NCT03261947` - A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors	Phase 2
Terminated	`NCT00094978` - Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum	Phase 1
Recruiting	`NCT02908204` - Long-term Outcomes of Superficial Esophageal Squamous Cell Carcinoma	N/A
Completed	`NCT02378948` - Nutritional Route In Esophageal Resection Trial II	N/A
Completed	`NCT02703142` - Endoscopic Evaluation After Esophagectomy	N/A
Recruiting	`NCT02604615` - The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy	Phase 3

NCT number	NCT05303740
Study type	Observational
Source	The First Affiliated Hospital of Zhengzhou University
Contact
Status	Completed
Phase
Start date	January 1, 2019
Completion date	March 1, 2022

Anlotinib Retrospective Study for Esophageal Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms